pH 3 holding time correlates with serum pepsinogen I/II ratio in patients with Helicobacter pylori-positive atrophic gastritis.

被引：0
|
作者：
Shimatani, T [1 ]
Inoue, M [1 ]
Horikawa, Y [1 ]
Kawai, Y [1 ]
Tao, C [1 ]
Kajiyama, G [1 ]
机构：
[1] Hiroshima Univ, Sch Med, Dept Internal Med 1, Hiroshima 734, Japan
来源：
GASTROENTEROLOGY | 1998年 / 114卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G1174
引用
收藏
页码：A286 / A286
页数：1
相关论文
共 29 条
  • [1] The diagnostic value of serum pepsinogen I, pepsinogen II and the pepsinogen I/II ratio combined with Helicobacter pylori tests in patients with early gastric cancer
    Yu, Hao
    Liu, Weihong
    Li, Li
    Wang, Xujie
    Kong, Qingbin
    Sui, Xin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (06): : 4376 - 4382
  • [2] Serum levels of pepsinogen I, pepsinogen II, and gastrin-17 in the course of Helicobacter pylori gastritis in pediatrics
    González-Roiz, C
    López-Rodriguez, MJ
    F-Pereira, T
    Zamorano, JDP
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2004, 39 (05): : 569 - 570
  • [3] Dynamics of Oxidative Stress in Helicobacter pylori-Positive Patients with Atrophic Body Gastritis and Various Stages of Gastric Cancer
    Tsukanov, Vladislav Vladimirovich
    Smirnova, Olga Valentinovna
    Kasparov, Edward Vilyamovich
    Sinyakov, Alexander Alexandrovich
    Vasyutin, Alexander Viktorovich
    Tonkikh, Julia Leongardovna
    Cherepnin, Mikhail Alexandrovich
    DIAGNOSTICS, 2022, 12 (05)
  • [4] Long-term proton pump inhibitor therapy accelerates the onset of atrophic gastritis in Helicobacter pylori-positive patients
    Kuipers, EJ
    Meuwissen, SGM
    HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000, 2000, : 255 - 267
  • [5] How does vitamin C administration decrease the risk of gastric cancer in the Helicobacter pylori-positive patients with atrophic gastritis?
    Tari, A
    Kitadai, Y
    Sumii, M
    Tani, H
    Tanaka, S
    Chayama, K
    HELICOBACTER, 2005, 10 (05) : 535 - 536
  • [6] Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran
    Hosseini, Mosalreza
    Amoueian, Sakineh
    Attaranzadeh, Armin
    Montazer, Mehdi
    Soltani, Ghodratollah
    Asadollahi, Khairollah
    Abangah, Ghobad
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2013, 18 (03): : 225 - 229
  • [7] Relation between Helicobacter pylori and atrophic gastritis in elderly: Estimation of serum (gastrin 17 and pepsinogen-I) as novel biomarkers
    Gomaa, Sekina I.
    Hassan, Azza
    El Sawy, Mohamed M.
    Ahmed, Eman Abd Z.
    Metwally, Mohamed
    ALEXANDRIA JOURNAL OF MEDICINE, 2012, 48 (04) : 289 - 294
  • [8] SERUM PEPSINOGEN-I AND PEPSINOGEN-II CONCENTRATIONS AND IGG ANTIBODY TO HELICOBACTER-PYLORI IN DYSPEPTIC PATIENTS
    BIASCO, G
    PAGANELLI, GM
    VAIRA, D
    HOLTON, J
    DIFEBO, G
    BRILLANTI, S
    MIGLIOLI, M
    BARBARA, L
    SAMLOFF, IM
    JOURNAL OF CLINICAL PATHOLOGY, 1993, 46 (09) : 826 - 828
  • [9] SERUM GASTRIN, PEPSINOGEN-I, PEPSINOGEN-II AND ANTIBODIES TO HELICOBACTER-PYLORI IN PATIENTS WITH GASTRIC POLYPS
    BONILLAPALACIOS, JJ
    MIYAZAKI, Y
    SHINOMURA, Y
    NAGAO, K
    YASUNAGA, Y
    MATSUZAWA, Y
    GASTROENTEROLOGY, 1993, 104 (04) : A43 - A43
  • [10] Pepsinogen I/II ratio may be an early serum marker of successful Helicobacter pylori eradication therapy.
    Takahashi, M
    Katayama, Y
    Takada, H
    Kuwayama, H
    GASTROENTEROLOGY, 2000, 118 (04) : A1312 - A1312
123